Acrisure Stock, Valuation, and IPO Potential
This page contains links to our partners. We may be compensated when a link is clicked. Read the disclosures to learn more.
Explore the potential for retail investors to own Acrisure stock. Access pre-IPO startups like Databricks, Anduril, and OpenAI via the Fundrise Innovation Fund*.
Acrisure Stock Recent News
07/12/2022: Steelers & Acrisure announce partnership
05/31/2022: Acrisure Closes $725 Million Equity Funding
03/24/2021: Acrisure Secures $3.4 Billion in Capital Raise
Older news…
What is Acrisure?
Acrisure is an insurance and fintech company based outside of Grand Rapids, MI, in the Caledonia suburb. Since its founding in 2005, the company has acquired hundreds of small-to-mid-sized insurance brokers that operate autonomously.
Its insurance broker companies offer home, auto, life, health, flood, and business insurance products for businesses and individuals.
The company also provides real estate, employee benefits, and cybersecurity services.
Acrisure’s proprietary AI-driven software platform, Auris, acquired from Pittsburgh-based Tulco in 2020, is used exclusively by acquired insurance brokers, giving small businesses access to operational efficiencies and sophisticated business intelligence.
Its software platform, Suvaun, streamlines employee benefits and healthcare insurance management.
The company called itself “the biggest company people never heard of” until purchasing the naming rights to Acrisure Arena in Palm Springs, California, and Acrisure Stadium, home of the Pittsburgh Steelers.
Acrisure’s future ambitions are unclear. It may be comfortable as a majority-employee-owned entity. But as it has grown into a $20 billion fintech, Wall Street investors may start asking why it is still private.
Here’s a recent commercial starring Lionel Richie:
Is Acrisure Stock Publicly Traded?
No. Acrisure is a private company.
Who Owns Acrisure?
Acrisure was previously wholly owned by private equity firm Genstar Capital. But management led a buyout to take control of the company in 2016.
In February 2021, Acrisure said it was 92% employee-, partner-, and management-owned. It has downplayed its employee-owned mantra since then.
Acrisure has taken on significant private funding to drive acquisitions in the past five years. Financial backers include Abu Dhabi Investment Authority (ADIA), Guggenheim Investments,
Oak Hill Advisors, BDT Capital Advisors, and a “consortium of investors” that own $454 million of Junior Preferred Stock
What Acrisure’s Valuation?
The current Acrisure valuation is $23 billion based on the latest funding round completed in May 2022.
When is the Acrisure IPO Date?
Acrisure has not indicated it has plans to conduct an IPO in the near future. The company ownership structure is such that management, agency partners, and employees hold a significant stake.
The extent to which non-management employees own stock and their available liquidity is unclear.
Since taking on significant private funding in 2021 and 2022, the company’s partners could influence it to become a public company if an IPO would offer value to stakeholders.
Furthermore, Acrisure’s publicity initiative, highlighted by purchasing the naming rights to the former Heinz Field in Pittsburgh, could be an early indication of raising awareness before becoming a public company.
However, Acrisure could be very comfortable as a private employee-owned company and may never go public. The path to a public listing is expensive and tedious due to the U.S. regulatory environment.
Bookmark this page to follow along as the company grows.
What is the Acrisure Stock Price?
Acrisure is not publicly traded. A public stock price is not available.
What is the Acrisure Stock Symbol? Acrisure Ticker?
If Acrisure pursues a public listing in the U.S., we will know the Acrisure stock symbol once it files an S-1 with the SEC.
For now, we can only speculate on the U.S. Acrisure ticker. Here are some suggestions:
- ACRI
- ACSR
- AS
Where can I find the Acrisure S-1 Filing?
Acrisure has not indicated plans for an IPO, so there is no S-1 filing available.
If the company chooses to list in the U.S., the S-1 filing will be the first documentation available for financial review.
How to Buy Acrisure Stock
Opportunities to own Acrisure stock are limited. The company has a high percentage of employee ownership, and we’ve seen no evidence that internal shareholders have accessed pre-IPO marketplaces for liquidity.
Most individual investors will not be able to buy Acrisure stock unless it pursues a public listing.
Here are some general methods for acquiring pre-IPO and IPO companies.
1. Access shares via pre-IPO investing platforms
It’s possible, though not likely at this stage, that Acrisure stock becomes available on a pre-IPO marketplace or in a venture capital fund such as the Fundrise Innovation Fund.
I have not seen evidence of pre-IPO availability on any platform or in any fund.
Acrisure direct investment shares may become available if early investors or employees want to cash out before an IPO. This may become more likely if the company raises another fresh round of private equity capital.
However, internal ownership restrictions may prevent such transactions. Publicly available information about employee ownership is limited, and ownership may be highly concentrated at the top.
The SEC requires pre-IPO investors to be accredited, meaning a net worth above $1 million (not including primary residence) or an income above $200,000 (or $300,000 with a spouse).
A few platforms have evolved to allow retail investors to own private companies via funding stock options or private sales. Prominent pre-IPO platforms include Linqto, Hiive, EquityZen, and Forge Global.
Check out our list of the best pre-IPO investing platforms for current platforms that may have shares available.
Please note: This is a testimonial in partnership with Fundrise. We earn a commission from partner links on AccessIPOs.com. All opinions are my own.
2. Buy Acrisure stock during the Acrisure IPO through a broker
Acrisure has not indicated it is interested in a public offering.
Interested investors can monitor company news on this website for new developments on the company’s future ownership aspirations.
If Acrisure pursues an IPO, underwriters may offer shares to retail investors.
Here’s a list of the top brokers for IPO investing.
Large brokers such as Fidelity and Charles Schwab sometimes receive IPO shares but often distribute them to their wealthiest clients.
However, brokers such as the following are more likely to offer retail investors the chance to acquire IPO shares:
These more retail-friendly brokers now compete for IPO shares for upcoming IPOs.
If your broker offers IPO access, join the email and text alerts for IPO access. There are no guarantees you’ll receive shares, but shares may be worth pursuing for some deals.
3. Buy Acrisure stock after the Acrisure IPO
Acrisure may never IPO. That would make it nearly impossible for retail investors to own the stock.
That said, the most likely scenario for retail investors to own Acrisure stock is to wait until after an IPO or SPAC to purchase shares.
Some companies choose to stay private as employee-owned own to avoid the additional expenses and regulatory scrutiny required to be a public company.
Acrisure News Archive
11/22/2016: Acrisure Completes $2.9 billion Buyout
Additional Resources
- 11 Fintech startups in the IPO Pipeline
Conclusion
Curiosity about Acrisure increased when it won the naming rights to the Pittsburgh Steelers stadium, similar to the Kasaya Center. The 15-year contract will increase its publicity as the company expands.
Better name recognition will help Acrisure acquire new insurance agency partners who receive exclusive access to its financial technology platforms.
Acrisure has not indicated it has plans to license its software to non-partners. The acquisition strategy remains the path forward.
Therefore, name recognition plays an important role in its growth, which may be the impetus behind acquiring the Steeler stadium rights.
However, it’s possible the naming deal could be the first step toward becoming a public company by raising awareness.
At a valuation of more than $20 billion, Acrisure has positioned itself as a fintech software company. Offering its software “as a service” (SaaS), a la Addepar, to non-partner agencies SaaS could increase the interests of Wall Street investors, who place inflated values on fintech and SaaS companies.
An IPO could unlock significant value for a growing company like Acrisure. Now that it has taken on private investors, they may advise to go public.
However, management purchased Acrisure from its previous private equity owner, Genstar Capital, to control its own destiny. Taking the company public from those origins could disrupt its corporate culture.
Monitor this page if you seek to own Acrisure stock or hope to see an Acrisure IPO in the future.
Craig Stephens is a former IT professional who left his 19-year consulting career at the IRS to be a full-time finance writer. A DIY investor since 1995, he started Access IPOs in 2016 to provide a resource for ordinary investors pursuing access to IPOs. Craig studied Finance at Michigan State University and lives in Northern Virginia with his wife and three children. Learn more about Craig.
Risk Statement: Investing in IPOs and pre-IPO startups involves significant risk. Do not invest in companies based solely on what is included in this article. Only invest in IPOs and pre-IPO companies with money you can afford to lose. Access IPOs is for informational purposes only. Mentions of specific investments should not be construed as financial advice. Conduct personalized research and consider consulting with an investment advisor before investing.
